Clinical trials
Pulmonary Fibrosis trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 11 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 13 |
| Unknown status | 11 |
| Not yet recruiting | 3 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hopital Foch | 2 |
| Hospital de Granollers | 2 |
| Mayo Clinic | 2 |
| National Jewish Health | 2 |
| Schön Klinik Berchtesgadener Land | 2 |
| University of North Carolina, Chapel Hill | 2 |
| Alexandria University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Bezmialem Vakif University | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 59 |
| Lung Diseases, Interstitial | 21 |
| Pulmonary Disease, Chronic Obstructive | 13 |
| Idiopathic Pulmonary Fibrosis | 8 |
| Bronchiectasis | 6 |
| Emphysema | 6 |
| Dyspnea | 5 |
| COVID-19 | 4 |
| Sarcoidosis | 4 |
| Asthma | 3 |
Trials
Showing 51 to 59 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.